Canada Pension Plan Investment Board Innoviva, Inc. Transaction History

Canada Pension Plan Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$15.39 - $20.25 $1.68 Million - $2.21 Million	-109,000 Reduced 96.63%	3,800 $74,000
Q3 2020 Nov 12, 2020	SELL	$10.33 - $14.49 $163,214 - $228,942	-15,800 Reduced 12.29%	112,800 $1.18 Million
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $1.48 Million - $1.96 Million	128,600 New	128,600 $1.8 Million
Q2 2019 Aug 12, 2019	SELL	$13.1 - $14.95 $213,176 - $243,281	-16,273 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $222,777 - $326,436	16,273 New	16,273 $228,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.